133 related articles for article (PubMed ID: 16751325)
1. Collecting direct non-health care and time cost data: application to screening and diagnosis of cervical cancer.
Cantor SB; Levy LB; Cárdenas-Turanzas M; Basen-Engquist K; Le T; Beck JR; Follen M
Med Decis Making; 2006; 26(3):265-72. PubMed ID: 16751325
[TBL] [Abstract][Full Text] [Related]
2. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
[TBL] [Abstract][Full Text] [Related]
3. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions?
Wang PE; Wang TT; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S54-8. PubMed ID: 17227644
[TBL] [Abstract][Full Text] [Related]
4. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
[TBL] [Abstract][Full Text] [Related]
5. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
6. Developing and testing a cost-assessment tool for cancer screening programs.
Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
Bennett CL; Calhoun EA
Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
[TBL] [Abstract][Full Text] [Related]
8. [Estimated cost of managing invasive cervical cancer in Tunisia].
Ben Gobrane H; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
Sante Publique; 2009; 21(6):561-9. PubMed ID: 20429226
[TBL] [Abstract][Full Text] [Related]
9. The cost of health care services provided to women enrolled in a community-based breast and cervical cancer screening program.
Burack R; Latafa J
J Health Care Poor Underserved; 2009 Aug; 20(3):713-20. PubMed ID: 19648699
[TBL] [Abstract][Full Text] [Related]
10. The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma.
Sherman EJ; Pfister DG; Ruchlin HS; Rubin DM; Radzyner MH; Kelleher GH; Slovin SF; Kelly WK; Scher HI
Cancer; 2001 Feb; 91(4):841-53. PubMed ID: 11241254
[TBL] [Abstract][Full Text] [Related]
11. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
Perovic S
J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
[TBL] [Abstract][Full Text] [Related]
12. Decision science and cervical cancer.
Cantor SB; Fahs MC; Mandelblatt JS; Myers ER; Sanders GD
Cancer; 2003 Nov; 98(9 Suppl):2003-8. PubMed ID: 14603536
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme.
Gordon L; Youl PH; Elwood M; Janda M; Ring IT; Lowe JB; Aitken JF
J Med Screen; 2007; 14(2):98-102. PubMed ID: 17626710
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
16. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
17. Using patients as their own controls for cost evaluation of phase I clinical trials.
Sherman EJ; Rubin DM; Venkatraman E; Schwartz GK; Miller VA; Radzyner MH; Ruchlin HS; Spriggs D; Pfister DG
J Clin Oncol; 2004 Apr; 22(7):1308-14. PubMed ID: 15051779
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
[TBL] [Abstract][Full Text] [Related]
19. [Cervical cancer screening and associated treatment costs in France].
Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
